NCT04196257 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04196257
Title	BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Bio-Path Holdings, Inc.
Indications	mixed epithelial tumor of ovary endometrial cancer endometrial transitional cell carcinoma ovary epithelial cancer endometrial mucinous adenocarcinoma ovarian squamous cell carcinoma Advanced Solid Tumor peritoneum cancer endometrial squamous cell carcinoma ovary transitional cell carcinoma endometrial clear cell adenocarcinoma ovarian serous carcinoma endometrial adenocarcinoma endometrial serous adenocarcinoma ovarian clear cell carcinoma fallopian tube cancer endometrial mixed adenocarcinoma
Therapies	BP1001-A BP1001-A + Paclitaxel
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Holy Cross Hospital	RECRUITING	Silver Spring	Maryland	20910	United States	Details
Karmanos Cancer Institute	RECRUITING	Detroit	Michigan	48201	United States	Details
Mary Crowley Cancer Research	RECRUITING	Dallas	Texas	75230	United States	Details
The University of Texas M.D. Anderson Cancer Center	RECRUITING	Houston	Texas	77030	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT04196257Clinical Trial Detail